Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents

Clinical Immunology

Volumn 142, Issue 2, 2012, Pages 201-208

  Siberry, George K ^a   Leister, Erin ^b   Jacobson, Denise L ^b   Foster, Samuel B ^c   Seage, George R ^b,d   Lipshultz, Steven E ^e   Paul, Mary E ^f   Purswani, Murli ^g   Colin, Andrew A ^e   Scott, Gwendolyn ^e   Shearer, William T ^f  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c Southwest Allergy and Asthma Center   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f TEXAS CHILDREN S HOSPITAL   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Asthma; Atopic dermatitis; Inhaled corticosteroids; Pediatric HIV infection; Protease inhibitors

Indexed keywords

ANTIRETROVIRUS AGENT; BECLOMETASONE; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; MOMETASONE FUROATE; MONTELUKAST; RITONAVIR; SALBUTAMOL; STEROID; TRIAMCINOLONE;

ADOLESCENT; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST; DRUG USE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERSTITIAL PNEUMONIA; LYMPHOID INTERSTITIAL PNEUMONITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTICENTER STUDY; PERINATAL PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; VIRUS LOAD;

ADOLESCENT; ASTHMA; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DERMATITIS, ATOPIC; DISEASE SUSCEPTIBILITY; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; RISK FACTORS;

EID: 84856520353     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.10.005     Document Type: Article

References (30)

1. Foster S.B., Lu M., Thompson B., et al. Association between HLA inheritance and asthma medication use in HIV-positive children. AIDS 2010, 24:2133-2135.
2. Foster S.B., McIntosh K., Thompson B., et al. Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study. J. Allergy Clin. Immunol. 2008, 122:159-165.
3. Foster S.B., Paul M.E., Kozinetz C.A., et al. Prevalence of asthma in children and young adults with HIV infection. J. Allergy Clin. Immunol. 2007, 119:750-752.
4. Gutin F., Butt A., Alame W., et al. Asthma in immune-competent children with human immunodeficiency virus. Ann. Allergy Asthma Immunol. 2009, 102:438.
5. Rudikoff D. The relationship between HIV-infection and atopic dermatitis. Curr Allergy Asthma Rep 2002, 2:275-281.
6. Soto P.C., Stein L.L., Hurtado-Ziola N., et al. Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation. J. Immunol. 2010, 184:4185-4195.
7. Reveille J.D., Williams F.M. Infection and musculoskeletal conditions: rheumatologic complications of HIV infection. Best Pract. Res. Clin. Rheumatol. 2006, 20:1159-1179.
8. van Dyke R.B., Wang L., Williams P.L. Toxicities associated dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children. J. Infect. Dis. 2008, 198(11):1599-1608. Pediatric ACTG 219c Team.
9. Aldrovandi G.M., Chu C., Shearer W.T., et al. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women. Pediatrics 2009, 124(6):e1189-e1197.
10. Martinez F.D., Wright A.L., Taussig L.M., et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N. Engl. J. Med. 1995, 332:133-138.
11. Castro-Rodriguez J.A., Holberg C.J., Wright A.L., et al. A clinical index to define risk of asthma in young children with recurrent wheezing. Am. J. Respir. Crit. Care Med. 2000, 162:1403-1406.
12. Brand P.L., Baraldi E., Bisgaard H., et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur. Respir. J. 2008, 32:1096-1110.
13. Gingo M.R., Wenzel S.E., Steele C., et al. Asthma diagnosis and airway bronchodilator response in HIV-infected individuals. J. Allergy Clin. Immunol. 2011, (accepted for publication).
14. Illi S., von Mutius E., Lau S., et al. The natural course of atopic dermatitis from birth to age 7years and the association with asthma. J. Allergy Clin. Immunol. 2004, 113(5):925-931. Multicenter Allergy Study Group.
15. Paul M.E., Shearer W.T. Human immunodeficiency virus and allergic disease. Middelton's Allergy: Principles and Practice 2009, Volume II:831-843. Mosby, St. Louis. 7th Edition. N.F. Adkinson, J.W. Yunginger, W.W. Busse, B. Bochner, S.T. Holgate, F.E.R. Simons (Eds.).
16. Lin R.Y., Lazarus T.S. Asthma and related atopic disorders in outpatients attending an urban HIV clinic. Ann. Allergy Asthma. Immunol. 1995, 74:510-515.
17. Galli L., Sabatino G., Zappa M., et al. Reduced frequency of wheezing respiratory illness in infants with perinatal human immunodeficiency virus-type 1 infection: a model for immunologic and inflammatory mechanisms of airway obstruction?. Pediatr. Allergy Immunol. 2003, 14:42-49.
18. Zar H.J. Chronic lung disease in human immunodeficiency virus (HIV) infected children. Pediatr. Pulmonol. 2008, 43(1):1-10.
19. Bisgaard H., Hermansen M.N., Buchvald F., et al. Childhood asthma after bacterial colonization of the airway in neonates. N. Engl. J. Med. 2007, 357:1487-1495.
20. Davis C.M., Shearer W.T. Diagnosis and management of HIV drug hypersensitivity. J. Allergy Clin. Immunol. 2008, 121:826-832.
21. Daniel T.D., Levy M.L. Cutaneous manifestations of pediatric HIV infection. Medical Management of AIDS in Children 2003, 271-289. Saunders, Philadelphia. W.T. Shearer, I.C. Hanson (Eds.).
22. Porter J.P., Patel A.A., Dewey C.M., et al. Prevalence of sinonasal symptoms in patients with HIV infection. Am. J. Rhinol. 1999, 13:203-208.
23. Lamhamedi-Cherradi S.-E., Martin R.E., Ito T., et al. Fungal proteases induce Th2 polarization through limited dendritic cells maturations and inhibition of IL-12 production. J. Immunol. 2008, 180:6000-6009.
24. Kheradmand F., Corry D.B. Discovery of novel markers in allergic lung inflammation through proteomic-based technologies. Expert Rev. Proteomics 2008, 5:9-12.
25. Porter P., Susarla S.C., Polikepahad S., et al. Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi. Mucosal Immunol. 2009, 2:504-517.
26. Arrington-Sanders R., Hutton N., Siberry G.K. Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents. Pediatr. Infect. Dis. J. 2006, 25:1044-1048.
27. Johnson S.R., Marion A.A., Vrchoticky T., et al. Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone. J. Pediatr. 2006, 148:386-388.
28. Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection August 16, 2010, 1-219. Available at. http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf.
29. Flovent [package insert] Research Triangle Park, NC: GlaxoSmithKline 2011.
30. Kaletra [package insert] North Chicago, IL: Abbott Laboratories 2011.